Development of strategic alliances between Russia and Hungary in the field of pharmaceuticals
- Authors: Chernysheva A.M.1, Degtereva E.A.1, Chernikov S.U.1
-
Affiliations:
- Peoples’ Friendship University of Russia (RUDN University)
- Issue: Vol 30, No 2 (2022): CHALLENGES OF EFFECTIVE GLOBAL GOVERNANCE IN THE POST-COVID ERA
- Pages: 220-230
- Section: INTERNATIONAL TRADE IN THE CONDITIONS OF GLOBALIZATION
- URL: https://journals.rcsi.science/2313-2329/article/view/324191
- DOI: https://doi.org/10.22363/2313-2329-2022-30-2-220-230
- ID: 324191
Cite item
Full Text
Abstract
The development of strategic alliances between Russian and foreign pharmaceutical companies allows not only to introduce biotechnologies in the domestic market, but also to strengthen the policy of import substitution and increase export volumes. That is why it is important to support the creation and functioning of strategic alliances at the state level. The purpose of this article is to study the creation and development of strategic alliances between Russia and Hungary, paying attention to the formation of alliances in the field of pharmaceuticals. In order to achieve this goal, the indicators of export-import operations between Russia and Hungary in the field of “pharmaceutical products”, as well as the main strategic alliances operating between the two countries were considered. It is assumed that the development of Russian-Hungarian strategic alliances in the field of pharmaceuticals with localization of production will help to achieve the goals of the import substitution policy in the field of drug production, as well as to intensify export operations. To test this hypothesis, documents published in the public domain were analyzed, including statistical data on export-import operations in the pharmaceutical market between Russia and Hungary. In general, it was proved that at the present stage of development of the pharmaceutical market of the Russian Federation, it is important to support the creation and functioning of strategic alliances, which will strengthen Russian positions not only in the domestic market, but also in the international market. Thus, the Russian Federation should actively develop and support the development of localized strategic alliances using various methods, which will increase the share of domestic biotechnologies and ensure their export.
About the authors
Anna M. Chernysheva
Peoples’ Friendship University of Russia (RUDN University)
Email: chernysheva_am@pfur.ru
PhD, Assistant Professor, Marketing department of the Faculty of Economics 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation
Ekaterina A. Degtereva
Peoples’ Friendship University of Russia (RUDN University)
Email: degtereva_ea@pfur.ru
PhD, Assistant Professor, Marketing department of the Faculty of Economics 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation
Sergey U. Chernikov
Peoples’ Friendship University of Russia (RUDN University)
Author for correspondence.
Email: chernikov_su@pfur.ru
PhD, Assistant Professor, Marketing department of the Faculty of Economics 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation
References
- Balakin, K. V., Aiginin, A. A., & Ivashchenko, A. A. (2021). Russian pharmaceutical industry in the horizon 2030. Analytical review. Dolgoprudniy. 62
- Bykova, E. A. Innovative processes in the Russian pharmaceutical market (2020). Bulletin of the University, (8), 57-64. (In Russ.) https://doi.org/10.26425/1816-4277-2020-8-57-64
- Chaplenko, A. A., Vlasov, V. V., & Gildeeva, G. N. (2020). Innovative drugs in the Russian pharmaceutical market: key players and main directions of development. Journal Remedium, 10, 4-9. (In Russ.) https://doi.org/10.21518/1561-5936-2020-10-4-9
- Gusakov, N. P., & Andronova, I. V. (2014). Common industrial policy: foreign practice and the experience for CIS. RUDN Journal of Economics, (3), 5-17. (In Russ.)
- Nekhoda Ye. V., Redchikova N. A., & Tyuleneva N. A. (2018). Business Models of Companies: From Profit to Sustainable Development and Value Creation. Upravlenets - The Manager, 9(4), 9-19. https://doi.org/10.29141/2218-5003-2018-9-4-2
- Nevskaya, A. A. (2014). Strategic alliances of companies from Russia and the EU. International Economics, (8), 11-15. (In Russ.)
- Pozhilova, E. V., Novikov, V. E., Guseva, E. S., & Savchenko, A. V. (2020). Counterfeit medicines and the fight against them in the Russian Federation. Reviews on Clinical Pharmacology and Drug Therapy, 18(1), 63-70. (In Russ.) https://doi.org/10.17816/RCF18163-70
- Romanova, S. A. (2019). Investment activity of pharmaceutical companies: interim results of 2019. Remedium, (11), 62-69. (In Russ) https://doi.org/10.21518/1561-5936-2019-11-62-69
- Zobov, A. M., Chernysheva, A. M., Degtereva, E. A., & Trofimova, A. A. (2018). Research and systematization of the existing practice in the countries implementing the import substitution policy for possible adaptation in the Russian Federation. Bulletin of the Academy of Knowledge, 3(26), 374-379. (In Russ.)
Supplementary files
